Hypertension, Pulmonary Clinical Trials
163 clinical trials for Hypertension, Pulmonary across international registries, including 7 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option — RECRUITING · PHASE3
- Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease — RECRUITING · PHASE2
- Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG — RECRUITING
- A Deep-Learning-Enabled Electrocardiogram for Detecting Pulmonary Hypertension — RECRUITING · NA
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension — RECRUITING · PHASE3
- Functional Pulmonary Capillary Surface Area in BPA for CTEPH — RECRUITING · NA
- Endtidal Carbon Dioxide for Earlier Detection of Pulmonary Hypertension — RECRUITING
- A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension — ACTIVE_NOT_RECRUITING · PHASE3
- Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023) — ACTIVE_NOT_RECRUITING · PHASE2
- Riociguat in Children With Pulmonary Arterial Hypertension (PAH) — ACTIVE_NOT_RECRUITING · PHASE3
- Vasopressor Agents in Pulmonary Hypertension Crisis — NOT_YET_RECRUITING · NA
- A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients — COMPLETED · PHASE3
- Study of Dehydroepiandrosterone (DHEA) in Respiratory Pulmonary Hypertension in Adults (DHEA-HTAP) — COMPLETED · PHASE2
- Study of Dehydroepiandrosterone (DHEA) in Respiratory Pulmonary Hypertension in Adults — COMPLETED · PHASE3
- Pulmonary Artery Remodelling With Bosentan — COMPLETED · PHASE4
- Inflammatory Biomarkers of Pediatric Pulmonary Hypertension — COMPLETED
- A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16) — COMPLETED · PHASE2
- A Long-term Extension Study of Riociguat in Patients With Symptomatic Pulmonary Arterial Hypertension. — COMPLETED · PHASE4
- A Study for the Identification of Biomarker Signatures for Early Detection of Pulmonary Hypertension (PH) — COMPLETED · PHASE1
- A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction — COMPLETED · PHASE2
- Impact of Multiple Doses of BAY63-2521 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Patients With Interstitial Lung Disease (ILD) Associated Pulmonary Hypertension (PH) — COMPLETED · PHASE2
- Treatment of Pulmonary Hypertension in High-risk Cardiac Surgery Patients Using Inhalational and Intravenous Agents — COMPLETED · NA
- A Study of the Efficacy and Safety of Frespaciguat (MK-5475) in Participants With Pulmonary Arterial Hypertension (INSIGNIA-PAH: Phase 2/3 Study of an Inhaled sGC Stimulator in PAH) (MK-5475-007) — COMPLETED · PHASE2
- This Study Tests the Safety of Inhaled BAY1237592, How the Drug is Tolerated and How it Effects Patients With High Blood Pressure in the Arteries of the Lungs in the Two Different Disease Groups Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH) — COMPLETED · PHASE1
- A Study of Selexipag in Participants Who Participated in a Previous Selexipag Study — COMPLETED · PHASE3
- A Study for the Identification of Biomarker Signatures for Diagnosis of Pulmonary Hypertension (PH) in Participants at Low or Intermediate Probability of PH Undergoing Cardiac Magnetic Resonance Imaging — COMPLETED · PHASE1
- The Effect of Pituitrin on the Patients With Pulmonary Hypertension Undergoing Cardiac Surgery — SUSPENDED · NA
- The Effect of Tracleer® on Male Fertility — COMPLETED · PHASE4
- Study of Angiogenic Cell Therapy for Progressive Pulmonary Hypertension — TERMINATED · PHASE2
- Endovenous Sildenafil Early Management in Newborns Pulmonary Hypertension — WITHDRAWN · NA
- Dietary Nitrate for Heart Failure — COMPLETED · PHASE1
- Acute Decompensation of Pulmonary Hypertension — COMPLETED · NA
- Lung Hyperinflation and Response to Pulmonary Vasodilator Therapy — COMPLETED
- Non-interventional, Postauthorization Safety Study of Ventavis for Pulmonary Arterial Hypertension (PAH) — COMPLETED
- Exercise Hemodynamic, Right Ventricular Coupling and Echocardiography in Pulmonary Hypertension — COMPLETED
- Prospective, Non-interventional, Multi-center Post-authorization Safety Study of Riociguat for Chronic Thromboembolic Pulmonary Hypertension (CTEPH ) — COMPLETED
- Early Feasibility Study Evaluating the 3P-100 Device in Subjects With PH-ILD — ACTIVE_NOT_RECRUITING · NA
- Prospective, Non-interventional, Multi-center, Post-authorization Safety Study of Riociguat for Pulmonary Arterial Hypertension (PAH) — COMPLETED
- Rapid Switch From Flolan to Remodulin in the Outpatient Clinic — TERMINATED · PHASE4
- Piloting Mindfulness Meditation Program for Underserved Racial Minority Adults With Pulmonary Hypertension — COMPLETED · NA
- BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension — COMPLETED · PHASE3
- Using Step Count to Enhance Daily Physical Activity in Pulmonary Hypertension — TERMINATED · NA
- Pedometers and Walking Tests for Pulmonary Hypertension Patients — OTHER · NA
- Hemodynamic Effects During Exercise in Patients With Pulmonary Hypertension Receiving Sildenafil — COMPLETED · NA
- Effects of Normobaric Hypoxia During Exercise in Patients With Pulmonary Hypertension Receiving Sildenafil — COMPLETED · NA
- Effects of Normobaric Hypoxia During Exercise in Patients With Pulmonary Hypertension With/Without Sildenafil — COMPLETED · NA
- Hemodynamic Effects of Normobaric Hypoxia During Exercise in Patients With Pulmonary Hypertension — COMPLETED · NA
- Blood Markers Predict Effect of Normobaric Hypoxia at Rest and During Exercise in Patients With Pulmonary Hypertension — COMPLETED · NA
- Tracking Outcomes and Practice in Pediatric Pulmonary Hypertension — COMPLETED
- Levosimendan Administration in Pulmonary Hypertension — COMPLETED · NA
Refine this search